INTERVIEW SNIPPET: Prof. Spencer discuss the outcomes of HaemaLogiX's KappaMab Phase 2 Trial
8 February 2024
INTERVIEW SNIPPET: Prof. Spencer discusses the clinical relevance of HaemaLogiX's targets, KMA & LMA
8 February 2024
INTERVIEW SNIPPET: Prof. Spencer explain the importance of HaemaLogiX's upcoming POM/DEX/KAPPA Trial
8 February 2024
INTERVIEW SNIPPET: Prof. Harrison explains why the science behind HaemaLogiX's technology makes sense
8 February 2024
INTERVIEW SNIPPET: Prof. Harrison discusses the clinical relevance of HaemaLogiX's targets, KMA & LMA
8 February 2024
INTERVIEW SNIPPET: Prof. Harrison explains his motivation to join the HaemaLogiX Scientific Advisory Board
1 February 2024
FULL VIDEO INTERVIEW: Professor Andrew Spencer discusses the clinical relevance of HaemaLogiX's targets KMA and LMA, and the clinical opportunity for our multi-platform portfolio of immunotherapy assets
1 February 2024
FULL VIDEO INTERVIEW: Prof. Harrison discusses the clinical relevance of HaemaLogiX's targets, KMA & LMA
26 May 2023
Karen Wilde, Myeloma Patient Story - Long Video
26 May 2023
Karen Wilde, Myeloma Patient Story - Short Video
15 March 2022
HaemaLogiX's Mary Sartor's presentation to the 63rd Annual ASH Annual Meeting in Atlanta, Georgia 2021
